FMR LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,243,753
-57.7%
7,563,076
-11.1%
0.00%
-50.0%
Q2 2023$19,490,346
-23.5%
8,511,068
-18.8%
0.00%
+100.0%
Q1 2023$25,467,600
+153.9%
10,480,494
+99.6%
0.00%0.0%
Q4 2022$10,030,718
-20.9%
5,251,685
-0.6%
0.00%0.0%
Q3 2022$12,679,000
+28.9%
5,282,999
-0.1%
0.00%0.0%
Q2 2022$9,840,000
-11.0%
5,290,614
+0.0%
0.00%0.0%
Q1 2022$11,057,000
-50.5%
5,290,549
-6.7%
0.00%
-50.0%
Q4 2021$22,333,000
-28.1%
5,668,138
-12.3%
0.00%0.0%
Q3 2021$31,079,000
-8.9%
6,461,356
-13.1%
0.00%
-33.3%
Q2 2021$34,133,000
-36.1%
7,436,513
-18.3%
0.00%
-40.0%
Q1 2021$53,434,000
+88.3%
9,102,838
+9.7%
0.01%
+66.7%
Q4 2020$28,379,000
+112.2%
8,298,100
-10.6%
0.00%
+200.0%
Q3 2020$13,372,000
-39.2%
9,285,974
-15.7%
0.00%
-50.0%
Q2 2020$21,983,000
-8.5%
11,019,274
-10.6%
0.00%
-33.3%
Q1 2020$24,027,000
-53.9%
12,321,594
-1.9%
0.00%
-50.0%
Q4 2019$52,122,000
+32.3%
12,559,494
-4.0%
0.01%
+20.0%
Q3 2019$39,386,000
-53.6%
13,084,894
-3.0%
0.01%
-50.0%
Q2 2019$84,840,000
+6.1%
13,488,094
-6.2%
0.01%0.0%
Q1 2019$79,947,000
-18.3%
14,378,914
-2.4%
0.01%
-23.1%
Q4 2018$97,871,000
-40.8%
14,739,614
-4.9%
0.01%
-31.6%
Q3 2018$165,427,000
-13.2%
15,503,980
-2.3%
0.02%
-13.6%
Q2 2018$190,497,000
+40.3%
15,874,780
+0.2%
0.02%
+37.5%
Q1 2018$135,738,000
-13.3%
15,838,774
+0.0%
0.02%
-11.1%
Q4 2017$156,481,000
-19.6%
15,838,169
+0.0%
0.02%
-25.0%
Q3 2017$194,639,000
-25.0%
15,837,216
+0.3%
0.02%
-25.0%
Q2 2017$259,668,000
+15.7%
15,785,280
+0.9%
0.03%
+10.3%
Q1 2017$224,390,000
+4.0%
15,647,859
+0.3%
0.03%0.0%
Q4 2016$215,823,000
-23.3%
15,605,451
+0.2%
0.03%
-21.6%
Q3 2016$281,528,000
+26.0%
15,579,856
+0.0%
0.04%
+19.4%
Q2 2016$223,476,000
+20.1%
15,573,212
+0.0%
0.03%
+19.2%
Q1 2016$186,007,000
-10.1%
15,565,448
+0.1%
0.03%
-7.1%
Q4 2015$206,883,000
+23.9%
15,543,413
+0.0%
0.03%
+16.7%
Q3 2015$166,921,000
+39.0%
15,541,961
+4.2%
0.02%
+60.0%
Q2 2015$120,066,00014,915,0920.02%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$37,033,000100.00%
Artal Group S.A. 58,274,650$499,413,0006.25%
SECTOR GAMMA AS 854,592$7,324,0001.32%
NEA Management Company, LLC 2,382,286$20,416,0000.91%
Virtus ETF Advisers LLC 89,845$770,0000.67%
Malaga Cove Capital, LLC 59,701$512,0000.28%
MARSHALL WACE, LLP 736,545$6,312,0000.26%
USS Investment Management Ltd 2,741,942$22,607,0000.25%
CLEARBRIDGE, LLC 1,172,117$10,045,0000.22%
WEDBUSH SECURITIES INC 155,396$1,332,0000.17%
View complete list of LEXICON PHARMACEUTICALS INC shareholders